Driver safety

In recent years, our strengthened efforts to promote driver safety worldwide have delivered some improvements and we are maintaining focus on this important area at all levels of the organisation. 

Our commitment centres on promoting driver safety among our sales forces – collectively the single largest group of employees who drive on company business – in total, some 22,000 people. 

We have three Driver Safety programmes in place: DriveSuccess for countries outside the US (this programme includes RideSuccess in India, Vietnam and Indonesia where our representatives currently use motorcycles) and Road Scholars within the US.  MedImmune, our biologics arm, also have a driver safety programme similar to Road Scholars.

These programmes take account of the different driving environments and associated risks across all the countries in which we do business, from our established markets in Europe and North America to our emerging markets in Eastern Europe, Asia Pacific, Latin America and Africa.  Procedures and standards are in place to ensure a common view on the effectiveness of all three programmes and to track performance globally. 

Because driving is our highest risk area for serious injury and fatality, we have made it a specific part of the global SHE strategy.  Driver safety targets are included in regional business scorecards which in turn are cascaded down to the individual marketing company scorecards in those regions. Performance is reported quarterly and this helps us to focus regional management and programme assistance on those marketing companies that need more help.

Read about our 2012 performance